GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Merus Labs International Inc (NAS:MSLI) » Definitions » ROIC %

Merus Labs International (Merus Labs International) ROIC % : 2.37% (As of Mar. 2017)


View and export this data going back to 1996. Start your Free Trial

What is Merus Labs International ROIC %?

ROIC % measures how well a company generates cash flow relative to the capital it has invested in its business. It is also called ROC %. Merus Labs International's annualized return on invested capital (ROIC %) for the quarter that ended in Mar. 2017 was 2.37%.

As of today (2024-04-26), Merus Labs International's WACC % is 0.00%. Merus Labs International's ROIC % is 0.00% (calculated using TTM income statement data). Merus Labs International earns returns that do not match up to its cost of capital. It will destroy value as it grows.


Merus Labs International ROIC % Historical Data

The historical data trend for Merus Labs International's ROIC % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Merus Labs International ROIC % Chart

Merus Labs International Annual Data
Trend Sep07 Sep08 Sep09 Sep10 Sep11 Sep12 Sep13 Sep14 Sep15 Sep16
ROIC %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -34.99 8.24 -3.18 0.50 0.13

Merus Labs International Quarterly Data
Jun12 Sep12 Dec12 Mar13 Jun13 Sep13 Dec13 Mar14 Jun14 Sep14 Dec14 Mar15 Jun15 Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17
ROIC % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -1.62 -2.07 -0.60 -4.41 2.37

Competitive Comparison of Merus Labs International's ROIC %

For the Drug Manufacturers - Specialty & Generic subindustry, Merus Labs International's ROIC %, along with its competitors' market caps and ROIC % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Merus Labs International's ROIC % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Merus Labs International's ROIC % distribution charts can be found below:

* The bar in red indicates where Merus Labs International's ROIC % falls into.



Merus Labs International ROIC % Calculation

Merus Labs International's annualized Return on Invested Capital (ROIC %) for the fiscal year that ended in Sep. 2016 is calculated as:

ROIC % (A: Sep. 2016 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (A: Sep. 2015 ) + Invested Capital (A: Sep. 2016 ))/ count )
=0.263 * ( 1 - -10.32% )/( (164.342 + 284.259)/ 2 )
=0.2901416/224.3005
=0.13 %

where

Merus Labs International's annualized Return on Invested Capital (ROIC %) for the quarter that ended in Mar. 2017 is calculated as:

ROIC % (Q: Mar. 2017 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Dec. 2016 ) + Invested Capital (Q: Mar. 2017 ))/ count )
=4.22 * ( 1 - -45.92% )/( (262.004 + 258.219)/ 2 )
=6.157824/260.1115
=2.37 %

where

Note: The Operating Income data used here is four times the quarterly (Mar. 2017) data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Merus Labs International  (NAS:MSLI) ROIC % Explanation

ROIC % measures how well a company generates cash flow relative to the capital it has invested in its business. It is also called ROC %. The reason book values of debt and equity are used is because the book values are the capital the company received when issuing the debt or receiving the equity investments.

There are four key components to this definition. The first is the use of operating income or EBIT rather than net income in the numerator. The second is the tax adjustment to this operating income or EBIT, computed as a hypothetical tax based on an effective or marginal tax rate. The third is the use of book values for invested capital, rather than market values. The final is the timing difference; the capital invested is from the end of the prior year whereas the operating income or EBIT is the current year's number.

Why is ROIC % important?

Because it costs money to raise capital. A firm that generates higher returns on investment than it costs the company to raise the capital needed for that investment is earning excess returns. A firm that expects to continue generating positive excess returns on new investments in the future will see its value increase as growth increases, whereas a firm that earns returns that do not match up to its cost of capital will destroy value as it grows.

As of today, Merus Labs International's WACC % is 0.00%. Merus Labs International's ROIC % is 0.00% (calculated using TTM income statement data).


Be Aware

Like ROE % and ROA %, ROIC % is calculated with only 12 months of data. Fluctuations in the company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.


Merus Labs International ROIC % Related Terms

Thank you for viewing the detailed overview of Merus Labs International's ROIC % provided by GuruFocus.com. Please click on the following links to see related term pages.


Merus Labs International (Merus Labs International) Business Description

Traded in Other Exchanges
N/A
Address
Merus Labs International Inc was incorporated on October 1, 2012 in British Columbia. The Company is a specialty pharmaceutical company. It acquires prescription medicines in various categories which include on patent but at maturity stage of product life cycle; branded generics; under promoted products; Niche market pharmaceuticals; and products with annual sales below critical threshold for large pharma. The Company competes with multinational pharmaceutical development corporations to small, single product companies that may limit their activities to a particular therapeutic area or region or territory.

Merus Labs International (Merus Labs International) Headlines